August 3, 2012

Mylan and Gilead Sciences have made an agreement under which Mylan will have rights to produce and market generic versions of Gilead drugs for HIV and AIDS in developing countries.

August 2, 2012

Teva Pharmaceutical Industries has named Carlo De Notaristefani as president and CEO of global operations and Aharon "Arik" Yaari as EVP community and institutional affairs, the Israeli drug maker said Thursday.

July 31, 2012

Abon Pharmaceuticals is challenging the patent protection on an injected drug used to treat leukemia in children and adolescents, the company said Tuesday.

July 31, 2012

CoramRx Specialty Pharmacy Services has received specialty pharmacy accreditation from URAC, the company announced.

July 30, 2012

A provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other specialty pharmacy medications has been awarded specialty pharmacy accreditation from URAC.

July 27, 2012

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 26, 2012

Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.

July 25, 2012

A division of Becton, Dickinson and Co. has introduced a thin-walled needle for injecting highly viscous drug formulations.

July 24, 2012

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.

July 24, 2012

A new organization aims to be an independent group to certify specialty pharmacists.

July 23, 2012

Nearly all healthcare professionals are satisfied with Diplomat Specialty Pharmacy's services, according to results of a survey released Monday.

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

July 23, 2012

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

July 17, 2012

A company that develops software for the specialty pharmacy and similar industries has integrated Armada Health Care's prior authorization system into its product.

July 17, 2012

A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.

July 16, 2012

Stopping a viral pandemic of any kind presents a major challenge that historically has often taken decades or even centuries, as occurred in the cases of polio and smallpox. But stopping or even slowing a pandemic is made all the more difficult when people who carry the virus face stigma and ignorance from their families, communities and governments.


July 16, 2012

The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

July 16, 2012

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

July 16, 2012

The Apothecary Shops has a new name, the specialty pharmacy provider said Monday.

July 11, 2012

Days after its acquisition of Coagulife, specialty pharmacy provider BioRx has received limited distribution rights to a treatment for a bleeding disorder described as one of the rarest in the world.

July 10, 2012

Diplomat Specialty Pharmacy has promoted its SVP managed markets and clinical services to SVP sales and marketing, the company said Tuesday.

July 10, 2012

President Barack Obama signed into law Monday what some called a "historic" reauthorization of the Prescription Drug User Fee Act.

July 9, 2012

Specialty pharmacy provider BioRx has acquired another specialty pharmacy provider based in Minnesota, BioRx said Monday.

July 9, 2012

The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.